Press Release | NeoGenomics Laboratories

May 23, 2019

NeoGenomics To Attend The 16th Annual Craig-Hallum Institutional Investor Conference

May 21, 2019

NeoGenomics Announces Pricing on Public Offering of Common Stock

May 20, 2019

NeoGenomics Announces Proposed Public Offering of Common Stock

April 30, 2019

NeoGenomics Reports 51% Revenue Growth to Record $96 Million in the First Quarter

April 3, 2019

NeoGenomics Schedules its First Quarter Earnings Release for April 30, 2019

April 2, 2019

NeoGenomics to Present at 18th Annual Needham & Company Health Care Conference

March 11, 2019

NeoGenomics Launches Immuno-Oncology Companion Diagnostic Test for Triple Negative Breast Cancer in Conjunction with FDA Approval for TECENTRIQ(R)

March 7, 2019

NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients